病灶内注射硫代硫酸钠治疗致残性肿瘤性钙质沉着症两例疗效观察
本文报告两例致残性肿瘤性钙质沉着症患者接受病灶内硫代硫酸钠注射治疗。一例为44岁女性皮肌炎患者,另一例为42岁男性家族性肿瘤性钙质沉着症患者,分别接受每周1-3g注射12和21个月。两例疼痛均缓解、钙质沉着显著缩小、功能明显改善,无特异性不良反应。
要点
- 病灶内注射硫代硫酸钠可缓解肿瘤性钙质沉着症疼痛并缩小病灶。
- 两例分别获59%和79%的病灶尺寸缩减,功能显著改善。
- 该疗法可能成为大型深部肿瘤性钙质沉着症的手术替代选择。
核心结论
- 局部注射硫代硫酸钠可能是治疗大型深部肿瘤性钙质沉着症的有前景策略,或可替代手术。
研究设计与样本
- 病例报告,共2例肿瘤性钙质沉着症患者接受病灶内硫代硫酸钠注射治疗。
主要发现
- 病例1为44岁女性皮肌炎患者,右肘大型皮下钙化,每周病灶内注射1-3g硫代硫酸钠共12个月,病灶从基线28.7*56.0mm缩小至治疗12个月时21.5*30.6mm(缩减59%)。
- 病例2为42岁男性家族性肿瘤性钙质沉着症患者,右臀部大型肌内钙化,每周病灶内注射1-3g硫代硫酸钠共21个月,病灶从基线167.5*204.3mm缩小至治疗21个月时86.2*85.2mm(缩减79%)。
- 两例均疼痛缓解、肿瘤性钙质沉着显著缩小、功能明显改善,无特异性不良反应。
关键数值与推荐
- 病例1:44岁女性,皮肌炎病史,右肘皮下钙化,每周病灶内注射1-3g硫代硫酸钠,疗程12个月。
- 病例2:42岁男性,家族性肿瘤性钙质沉着症,右臀部肌内钙化,每周病灶内注射1-3g硫代硫酸钠,疗程21个月。
临床怎么用
- 对大型深部肿瘤性钙质沉着症病灶,可考虑病灶内注射硫代硫酸钠作为手术替代方案。
- 治疗采用每周1-3g病灶内注射,需根据病灶大小和深度个体化调整疗程。
局限性
- 仅为两例病例报告,样本量极小,疗效和安全性需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tumoral calcinosis (TC) is a difficult-to-treat complication that can occur during several diseases such as dermatomyositis or genetic hyperphosphatemia. It is a painful and disabling condition that can lead to local complications including joint mobility reduction, cutaneous ulceration and superinfection. For the largest lesions, the treatment relies essentially on surgery. Intravenous sodium thiosulfate (STS) is efficient to treat calciphylaxis in patients undergoing hemodialysis. Local injections of STS seem efficient in superficial calcifications. OBJECTIVE: To report the efficacy and safety of intra-lesional injections of STS in tumoral calcinosis. RESULTS: We report two cases of successful intra-lesional injections of STS. A 44-year-old woman, with a history of dermatomyositis, presenting large subcutaneous calcifications in the right elbow, and a 42-year-old man, with a history of familial tumoral calcinosis, presenting large intramuscular calcifications in the right buttock, received weekly intra-lesional of 1-3g STS injections for 12 and 21 months, respectively. In both cases, the treatment relieved pain and greatly reduced the tumoral calcinosis with a very significant functional improvement without specific adverse effects. In case 1, TC size decreased from 28.7*56.0mm at baseline to 21.5*30.6mm at M12 treatment (59% reduction). In case 2, TC reduced from 167.5*204.3mm at baseline to 86.2*85.2mm at M21 treatment (79% reduction). CONCLUSION: Local injection of STS could be a promising therapeutic strategy for large and deep TC lesions and could therefore be an alternative to surgery.
引用
- Goossens J, Courbebaisse M, Caudron E, et al. Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: Two cases. Semin Arthritis Rheum. 2017. PMID: 28779847. doi:10.1016/j.semarthrit.2017.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。